ScImage announced that it is delivering a fully customizable reporting and workflow documentation solution for vascular procedures. The reporting solution will be offered as an add-on to the company’s award winning Enterprise PACS solution, PicomEnterprise.
The results of Boston Scientific's pivotal SPIRIT III clinical trial reaffirmed prior safety and efficacy data for the market-leading TAXUS Express2 Paclitaxel-Eluting Coronary Stent System and provided early positive data for the XIENCE V (PROMUS) Everolimus-Eluting Coronary Stent System.
As the pioneer of metabolic assessment and behavioral therapy technologies, BodyMedia is developing tools that empower health professionals to better treat patients with chronic health conditions such as obesity, diabetes and cardiovascular disease (CVD).
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Data released from the bridge-to-transplantation (BTT) arm of the HeartMate II Pivotal trial demonstrate that the device provides effective mechanical circulatory support as a bridge to transplantation for heart failure patients, and that these patients experience a lower number of adverse events and an improved quality of life while being supported by the device.
ZOLL Medical Corp. has received FDA clearance to market and sell the ZOLL M Series with Real CPR Help technology. The device enables rescuers to instantly see and hear how well they are performing the rate and depth of CPR chest compressions. The M Series is the Company’s best-selling product to date. The approval extends Real CPR Help to ZOLL’s complete defibrillator product line.
Boston Scientific Corp. announced two-year results from the TAXUS V In-Stent Restenosis (ISR) trial, demonstrating that the TAXUS Express2 paclitaxel-eluting coronary stent system met its primary endpoint in the treatment of in-stent restenosis - the regrowth of diseased tissue into a previously stented artery utilizing bare-metal stents - compared to vascular brachytherapy.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
VIASYS Healthcare is showcasing the launch of the MasterScreen CPX, a product that combines 40 years of CPET experience into a compact unit.
Pfizer says the FDA has approved the company’s Lipitor (atorvastatin calcium) Tablets to reduce the risk of nonfatal heart attacks, fatal and non-fatal strokes, certain types of heart surgery, hospitalization for heart failure, and chest pain in patients with heart disease — making Lipitor the first cholesterol-lowering medication to receive FDA approval for the reduction of the risk of hospit
Diagnosoft HARP is software that assists physicians in the analysis of magnetic resonance (MR) images by providing quantitative measurements and visualization of regional heart function. Based on technology from Johns Hopkins University, it’s the first FDA-cleared software designed for the analysis of tagged MR images.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The NICO2 Respiratory Profile Monitor is designed to monitor the patient side of the breathing circuit. NICO2 goes beyond conventional capnography to measure breath-by-breath volumetric CO2 and takes the guesswork out of ventilation management from setup to weaning.
Rcadia Medical Imaging Ltd., an Israel-based developer of novel computer-aided diagnostic software, has received FDA clearance to market its COR Analyzer I, which assists screening of triage patients for coronary artery disease.
Exercise Tolerance Testing (ETT) is a diagnostic tool consisting of the RHE cycle, that is used in conjunction with scientifically validated exercise testing protocols to create a more accurate, sensitive and comfortable test, according to the company.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
The intra-aortic balloon pump (IABP) is an minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart function.
Sentinel integrates the entire range of noninvasive diagnostic cardiology solutions including: ECG Exercise Testing, 12-Lead ECG, Holter Monitoring, ECG Event Recording and Ambulatory Blood Pressure Monitoring into one central data management system.
MasterScreen CPX is a complete exercise test that includes a stress ECG option. Its digital TripleV-Volume Sensor complies with ATS criteria, performs without drift and is completely insensitive to moisture. It features a lightweight design (45g), minimal resistance to airflow, dead space of 30mL and it can be used for all patient populations.